In our latest 🎙️Trade To Black Podcast @ShandrawCody - Founder of @HealingReit believes that if the FDA approves Lykos Therapeutics (formerly @MAPS) MDMA-assisted therapy for #ptsd we could see the following for psychedelic stocks ..
“I think you could see a market move unlike anything for an industry throughout public markets history”
Target action date is slated for August 11, 2024.
https://t.co/w6iFMCvRBV
$CYBN $CMPS $ATAI $NUMIF $MNMD
#psychedelics #psychedelicstocks #mentalhealth @V_arrell
Over 50% of new drug applications submitted to the FDA are psychedel!c related molecules
All of these emerging treatments will need to be done inside of a brick and mortar clinic
@HealingReit we are building out that infrastructure in order to expand access in the healthcare space as it relates to therapies that are revolutionizing neurological, mental and behavioral health treatments
Onward
@AdvisorShares@mpadvisorshares@ShandrawCody
In an exclusive interview with The Fly, @HealingReit#president talks behavioral treatment #infrastructure, challenges, opportunities and more. Catch up in "Rising High" weekly from @theflynews $ACB $CVSI $CRON $CGC $ATAI $RLMD $CMPS $CMND $NUMIF $CRLBF https://t.co/8UI0VrzQSQ
In this episode, we explore the intriguing fusion of real estate and the emerging world of psychedelic therapy.
Join @CaltabianoJoe and @ShandrawCody on the PS podcast for an eye-opening discussion. 🏡
Don't miss out – listen in now!
https://t.co/YRokKW6QFL🎧👇
Does #RealEstate stand to play an integral role in the infrastructure being developed to support #psychedelic clinical therapies?
In the latest episode of the @PSYC_Spot Podcast, I sit down with @ShandrawCody and Joseph Caltabiano of the @HealingReit to discuss exactly how they are developing and positioning the @HealingReit to strategically tap into the fundamentals of real estate with an intent of creating a win-win scenario that expands beyond their company's stakeholders and into a healthcare system that is preparing to incorporate many of these psychedelic-related therapies which are poised to revolutionize our approach to treating so many different mental and physical health conditions.
Watch or listen here 👇
https://t.co/5j0uGTU4Db
Please vote for my good friend and one of the best humans you’ll ever meet. Every single dollar that goes to @NoFallenHeroes goes to helping #Veterans#firstresponders and the spouses of both
We are deeply saddened for the loss of Roland Griffiths after his battle with cancer.
He was an unforgettable pioneer in psychedelic research, and nothing we now do would be possible without him. A huge inspiration for all of us ❤️
Congratulations to everyone @MAPS as #MDMA & therapy takes a final step to being available the role of therapy centres that are fit for the future is never more pressing. https://t.co/cGUxSUWFBJ
We were excited to preview our new Centre for Mental Health Research and Innovation last month in London, ahead of its official opening this autumn. The centre has been developed together with South London and Maudsley NHS Foundation Trust (SLaM), the largest mental health trust in the UK NHS and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London. This pioneering collaboration aims to provide patient access to cutting edge research studies in multiple areas of high unmet need in mental health. To learn more about the collaboration, read the full press release: https://t.co/yQEhHxvfq0